Longitudinal Free-Water Changes in Dementia with Lewy Bodies
Shannon Y Chiu1,2, Robin Chen3, Wei-En Wang3
1Department of Neurology, University of Florida, Gainesville, Florida, USA.
Background:
Diffusion-weighted magnetic resonance imaging (dMRI) examines tissue microstructure integrity in vivo. Prior dementia with Lewy bodies (DLB) diffusion tensor imaging studies yielded mixed results.
Objective:
We employed free-water (FW) imaging to assess DLB progression and correlate with clinical decline in DLB.
Methods:
Baseline and follow-up MRIs were obtained at 12 and/or 24 months for 27 individuals with DLB or mild cognitive impairment with Lewy bodies (MCI-LB). FW was analyzed using the Mayo Clinic Adult Lifespan Template. Primary outcomes were FW differences between baseline and 12 or 24 months. To compare FW change longitudinally, we included 20 cognitively unimpaired individuals from the Alzheimer's Disease Neuroimaging Initiative.
Results:
We followed 23 participants to 12 months and 16 participants to 24 months. Both groups had worsening in Montreal Cognitive Assessment (MoCA) and Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) scores. We found significant FW increases at both time points compared to baseline in the insula, amygdala, posterior cingulum, parahippocampal, entorhinal, supramarginal, fusiform, retrosplenial, and Rolandic operculum regions. At 24 months, we found more widespread microstructural changes in regions implicated in visuospatial processing, motor, and cholinergic functions. Between-group analyses (DLB vs. controls) confirmed significant FW changes over 24 months in most of these regions. FW changes were associated with longitudinal worsening of MDS-UPDRS and MoCA scores.
Conclusions:
FW increased in gray and white matter regions in DLB, likely due to neurodegenerative pathology associated with disease progression. FW change was associated with clinical decline. The findings support dMRI as a promising tool to track disease progression in DLB. © 2024 International Parkinson and Movement Disorder Society.
Insights
Free-water (FW) imaging revealed increased neurodegeneration in dementia with Lewy bodies (DLB) over time. These microstructural changes correlated with cognitive and motor decline, supporting dMRI as a tool for tracking DLB progression.
Area of Science:
- Neuroimaging
- Neurodegenerative Diseases
- Biomarkers
Background:
- Diffusion-weighted magnetic resonance imaging (dMRI) assesses in vivo tissue microstructure.
- Previous dMRI studies in dementia with Lewy bodies (DLB) have shown inconsistent findings.
Purpose of the Study:
- To utilize free-water (FW) imaging to evaluate DLB progression.
- To correlate FW changes with clinical decline in DLB patients.
Main Methods:
- Baseline and follow-up MRIs were acquired at 12 and 24 months for 27 individuals with DLB or mild cognitive impairment with Lewy bodies (MCI-LB).
- Free-water (FW) was analyzed using the Mayo Clinic Adult Lifespan Template.
- 20 cognitively unimpaired individuals from the Alzheimer's Disease Neuroimaging Initiative were included for longitudinal comparison.
Main Results:
- Significant FW increases were observed in multiple brain regions, including the insula, amygdala, and cingulate cortex, at 12 and 24 months compared to baseline.
- More widespread microstructural changes, particularly in areas related to visuospatial processing, motor, and cholinergic functions, were noted at 24 months.
- FW changes were significantly associated with longitudinal worsening of cognitive (Montreal Cognitive Assessment - MoCA) and motor (Movement Disorder Society-Unified Parkinson's Disease Rating Scale - MDS-UPDRS) scores.
Conclusions:
- Free-water (FW) accumulation in gray and white matter regions indicates neurodegenerative pathology and disease progression in DLB.
- The observed association between FW changes and clinical decline highlights its potential as a marker for DLB progression.
- dMRI, specifically FW imaging, shows promise as a tool for monitoring disease progression in DLB.
Related Concept Videos
Dementia
The progression of dementia is generally gradual....
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...


